P. Savvides

2.8k total citations
89 papers, 1.7k citations indexed

About

P. Savvides is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P. Savvides has authored 89 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 37 papers in Otorhinolaryngology and 30 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P. Savvides's work include Head and Neck Cancer Studies (37 papers), Lung Cancer Treatments and Mutations (20 papers) and Lung Cancer Research Studies (17 papers). P. Savvides is often cited by papers focused on Head and Neck Cancer Studies (37 papers), Lung Cancer Treatments and Mutations (20 papers) and Lung Cancer Research Studies (17 papers). P. Savvides collaborates with scholars based in United States, Greece and Sweden. P. Savvides's co-authors include Pierre Lavertu, Jay Wasman, Athanassios Argiris, Pingfu Fu, Scot C. Remick, Afshin Dowlati, Govardhanan Nagaiah, Eva Kahana, Nathan A. Berger and Matthew M. Cooney and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

P. Savvides

83 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Savvides United States 20 734 455 406 307 292 89 1.7k
Guy Andry Belgium 29 755 1.0× 729 1.6× 364 0.9× 436 1.4× 700 2.4× 113 2.6k
Brandon G. Bentz United States 19 336 0.5× 501 1.1× 271 0.7× 204 0.7× 312 1.1× 40 1.6k
Jean-Michel Vannetzel France 14 715 1.0× 160 0.4× 383 0.9× 146 0.5× 80 0.3× 28 1.4k
Jamal Zidan Israel 23 518 0.7× 309 0.7× 191 0.5× 60 0.2× 252 0.9× 80 1.5k
Victoria J. Sinibaldi United States 23 843 1.1× 535 1.2× 1.1k 2.7× 52 0.2× 224 0.8× 57 2.0k
Mustafa Ascha United States 16 192 0.3× 283 0.6× 229 0.6× 78 0.3× 308 1.1× 58 2.0k
Werner Rittgen Germany 24 1.0k 1.4× 843 1.9× 278 0.7× 219 0.7× 37 0.1× 38 2.0k
Laura Zanotti Italy 27 527 0.7× 546 1.2× 341 0.8× 26 0.1× 202 0.7× 76 1.9k
Michael Bergqvist Sweden 27 873 1.2× 1.1k 2.4× 686 1.7× 74 0.2× 63 0.2× 112 2.5k
Reinhard von Roemeling United States 23 728 1.0× 774 1.7× 626 1.5× 64 0.2× 54 0.2× 72 2.0k

Countries citing papers authored by P. Savvides

Since Specialization
Citations

This map shows the geographic impact of P. Savvides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Savvides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Savvides more than expected).

Fields of papers citing papers by P. Savvides

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Savvides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Savvides. The network helps show where P. Savvides may publish in the future.

Co-authorship network of co-authors of P. Savvides

This figure shows the co-authorship network connecting the top 25 collaborators of P. Savvides. A scholar is included among the top collaborators of P. Savvides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Savvides. P. Savvides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gibson, Michael K., P. Savvides, Francis P. Worden, et al.. (2024). Phase II Trial Assessing Safety, Efficacy and Immune Correlates of Heterologous Prime-Boost with pBI-11 (IM) and TA-HPV (IM) Plus Pembrolizumab for Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer. International Journal of Radiation Oncology*Biology*Physics. 118(5). e89–e90.
2.
Desai, Aakash, Sagar Rakshit, Radhika Bansal, et al.. (2023). Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report. Cancer Treatment and Research Communications. 36. 100743–100743. 15 indexed citations
3.
Argiris, Athanassios, Yael Flamand, P. Savvides, et al.. (2023). A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305. European Journal of Cancer. 199. 113509–113509.
4.
Desai, Aakash, Jacob J. Orme, Saurabh Zanwar, et al.. (2023). Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer. Clinical Lung Cancer. 24(8). 689–695.e1. 15 indexed citations
5.
6.
Eads, Jennifer R., Smitha Krishnamurthi, Joel Saltzman, et al.. (2020). Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors. Investigational New Drugs. 39(1). 142–151. 10 indexed citations
7.
Savvides, P., et al.. (2019). Inter- and intra-rater reliability of vertebral fracture classifications in the Swedish fracture register. World Journal of Orthopedics. 10(1). 14–22. 9 indexed citations
8.
Argiris, Athanassios, Αthanasios Kotsakis, Tien Hoang, et al.. (2012). Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck. Annals of Oncology. 24(1). 220–225. 115 indexed citations
9.
Yang, Shuming, P. Savvides, Lili Liu, Stanton L. Gerson, & Yan Xu. (2012). Development and validation of an LC–MS/MS method for pharmacokinetic study of methoxyamine in phase I clinical trial. Journal of Chromatography B. 901. 25–33. 3 indexed citations
10.
Argiris, Athanassios, Michalis V. Karamouzis, William E. Gooding, et al.. (2011). Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer. Journal of Clinical Oncology. 29(9). 1140–1145. 84 indexed citations
11.
Yao, Min, Minggen Lu, P. Savvides, et al.. (2011). Distant Metastases in Head-and-Neck Squamous Cell Carcinoma Treated With Intensity-Modulated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 83(2). 684–689. 36 indexed citations
12.
Savvides, P.. (2010). The Role of Chemotherapy in the Management of Patients with Head and Neck Cancer. Seminars in Plastic Surgery. 24(2). 137–147. 6 indexed citations
13.
Nock, Charles, Joanna M. Brell, Joseph A. Bokar, et al.. (2009). A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors. Investigational New Drugs. 29(1). 126–130. 17 indexed citations
14.
Pagedar, Nitin A., Daniel Chen, Jay Wasman, et al.. (2008). Molecular Classification of Thyroid Nodules by Cytology. The Laryngoscope. 118(4). 692–696. 9 indexed citations
15.
Alcelik, Ilhan, et al.. (2006). Osteotomy of the femoral neck for severe slipped capital femoral epiphysis. Injury Extra. 38(1). 29–29. 1 indexed citations
16.
Savvides, P., Norma Terrin, John K. Erban, & Harry P. Selker. (2003). Development and validation of a patient-specific predictive instrument for the need for dose reduction in chemotherapy for breast cancer: a potential decision aid for the use of myeloid growth factors. Supportive Care in Cancer. 11(5). 313–320. 16 indexed citations
17.
Makrigiorgos, G. Mike, Amin I. Kassis, Ashfaq Mahmood, Edward A. Bump, & P. Savvides. (1997). Novel Fluorescein-Based Flow-Cytometric Method For Detection of Lipid Peroxidation. Free Radical Biology and Medicine. 22(1-2). 93–100. 45 indexed citations
18.
Savvides, P., et al.. (1993). Combined spectrin and ankyrin deficiency is common in autosomal dominant hereditary spherocytosis. Blood. 82(10). 2953–2960. 68 indexed citations
19.
Stamatelos, G., et al.. (1989). Pseudoxanthoma elasticum and angioid streaks in two cases ofβ-thalassaemia. Clinical Rheumatology. 8(4). 522–527. 8 indexed citations
20.
Aessopos, Athanasios, et al.. (1989). Angioid Streaks in Homozygous β Thalassemia. American Journal of Ophthalmology. 108(4). 356–359. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guy Andry Breakdown of academic impact, for papers by Brandon G. Bentz Breakdown of academic impact, for papers by Jean-Michel Vannetzel Breakdown of academic impact, for papers by Jamal Zidan Breakdown of academic impact, for papers by Victoria J. Sinibaldi Breakdown of academic impact, for papers by Mustafa Ascha Breakdown of academic impact, for papers by Werner Rittgen Breakdown of academic impact, for papers by Laura Zanotti Breakdown of academic impact, for papers by Michael Bergqvist Breakdown of academic impact, for papers by Reinhard von Roemeling
Rankless by CCL
2026